Abstract
The term Marfan’s syndrome (MFS) indicates a connective tissue disorder which causes skin, ocular, skeletal, and cardiovascular abnormalities.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
1 Marfan’s Syndrome
The term Marfan’s syndrome (MFS) indicates a connective tissue disorder which causes skin, ocular, skeletal, and cardiovascular abnormalities.
The first description of the marfanoid habitus was made by Prof. A.B.J. Marfan [1] in 1896, when, at a meeting of the Société Médicale des Hopitaux de Paris, he reported the case of a 5-year-old girl with asthenic physical conformation and excessive length of limbs, fingers, and toes (spider’s legs, arachnodactyly).
In a clinical update, published on Circulation in 2005, Milewicz et al. [2] define MFS as a hereditary disorder of the connective tissue with a prevalence of about 1 in 3000–5000 individuals. The syndrome is due to a mutation in the FBN-1 gene, located in chromosome 15 and encoding for fibrillin-1, a glycoprotein which is a major component of the extracellular matrix fibrils [3, 4].
The largely known life-threatening complication of this syndrome is represented by the progressive enlargement of the ascending aorta, leading to aortic regurgitation, aneurysm, and rupture. In past times, this complication implied a life expectancy no longer than 45 years in the majority of the patients [5]; according to McCusick [6], less than 10% of MFS patients lived more than 40 years. In about 75% of the cases, MFS is inherited according to an autosomal dominant pathway with complete penetration and variable phenotypic expression [2]; in about 25% of the cases, the mutation is sporadic. The diagnosis is based mainly on clinical findings, the so-called Ghent criteria [7, 8].
Renal cysts are not included into the diagnostic parameters; however, familial co-occurrence of MFS and adult polycystic kidney disease, due to a mutation in the PKD-1 gene located in chromosome 16 [9], has been reported [10]. This kidney disease has been found to be associated with vascular abnormalities, in particular with abdominal aortic aneurysms [11].
As the most common, and most life-threatening, manifestation of MFS is the involvement of the aortic root and ascending aorta, the current follow-up protocol is based on the systematic investigation of the heart and thoracic aorta [12]. However, after a number of case reports regarding aneurysms of the abdominal aorta and peripheral arteries and the extended life expectancy in MFS patients due to the remarkable results of cardiovascular surgery, attention is being focused on aneurysms outside the thoracic aorta in young, young adult, and adult patients.
In 2011, Yetman et al. [13] reported the study of 140 adult (>18 years) patients, after ruling out the possibility of Loeys–Dietz syndrome [14] through the specific genetic testing for mutation of TGFBR1/TGFBR2; about one-third of the patients presented aneurysms involving the abdominal aorta and/or peripheral arteries. This finding offered some degree of correlation with prior aortic surgery and the presence of risk factors like smoking. The authors concluded that surveillance also of distal aorta and peripheral arteries is warranted in adult MFS patients. In 2014, Gaertner et al. [15] corroborated this statement through a meticulous ultrasound study of 15 MFS patients aged 27–44 years: they found that 10 (67%) presented aneurysms outside the thoraco-abdominal aorta (three iliac, one femoral, one popliteal, one brachiocephalic, two subclavian, two vertebral, one renal).
Aneurysms of the abdominal aorta may be associated with aneurysm of the thoracic aorta [16, 17] and are not frequent, representing about 10% with respect to thoracic aortic aneurysms, according to Takayama et al. [18], who reported six cases. However, they may be isolated [19]. Lafferty et al. [20] described a ruptured abdominal aortic aneurysm; in 1982, Roberts and Honig [21] were able to find only eight cases of fusiform abdominal aortic aneurysm reviewing the English language literature from 1951. The association with popliteal aneurysm was the object of case reports [22, 23].
Subclavian aneurysms [24, 25] seem to be treated effectively through endovascular procedures [26]. A case of bilateral axillary aneurysm in siblings was reported by Saito et al. [27]. In 2006, Nguyen et al. [28] described a case of ulnar artery aneurysm.
Aneurysmal disease of extracranial cervical arteries has been reported repeatedly [29,30,31,32]. The occurrence of aneurysms of the intracranial carotid artery [33, 34] is contested by Conway et al. [35]
Aneurysms of the iliac arteries are not rare [36,37,38], occasionally ruptured [39]. Rupture followed sport activity in the case reported by Aschwanden et al. [40]; in the case report by Mounier-Behier et al. [41], a dissecting iliac aneurysm was the first clinical sign of MFS. Recently, gratifying results with the treatment of iliac aneurysms in MFS by stent grafting with the sandwich technique have been reported [42, 43].
Aneurysms of the femoral artery are very rare, one case being described by Hatrick et al. [44].
In Table 26.1, the cases of popliteal aneurysm are outlined.
2 Ehlers–Danlos Syndrome
Under the name of Ehlers–Danlos syndrome (EDS), several heritable disorders of the connective tissue are comprised, classically manifesting, from the clinical point of view, through skin hyperextensibility, joint hypermobility, and tissue friability.
The eponym pays a tribute to the accurate clinical observations and descriptions by E. Ehlers [46] in 1901 and H.A. Danlos [47] in 1908. However, typical “EDS” cases had been reported, in 1892, by Tschernogobow [48] and, already in 1682, the Belgian surgeon Van Meekren [49] illustrated, on the front cover of his book Observationes medico-chirurgicae, a young man with exceptional elasticity of the skin (de extraordinaria dilatabilitate cutis) (Fig. 26.1).
Several types of EDS were recognized through the years, amounting to eleven or more, following a Roman numeral list. This classification was ruled and simplified through the so-called Villefranche nosology [50]: from 1997 six types of EDS are recognized, identified with a descriptive method. The former type IV EDS is now called vascular EDS, characterized by an impressive incidence of heavy arterial complications and as well, but in a less catastrophic way, by rupture of the intestine and of the gravid uterus.
Owing to these life-threatening complications, type IV EDS focused particular attention by clinicians, deserving the private eponym of Sack–Barabas syndrome, from the work of G. Sack [51] (credited for having described in 1936 the first case of vascular EDS) and of A.P. Barabas [52, 53] (who gave the appellative of arterial to type IV EDS and reported five cases, of which one with fatal aortic rupture). Barabas’ cases enlightened some of the complications of the disease: tears of major arteries, aortic rupture, arteriovenous fistulae, varicose veins.
In general, even after Villefranche, the appellative type IV EDS continues being used, together with those of arterial, vascular, or ecchymotic [54].
Vascular EDS is caused by a heterozygote mutation of the gene COL3A1, located in chromosome 2, encoding for type III collagen; the mutation is transmitted by autosomal dominant trait [55]; several molecular mechanisms have been described and most mutations are unique for each family, without any correlation between genotype and phenotype [56]. The striking decrease in the production of collagen III was demonstrated by Pope [57]; Cikrit et al. [58], reporting on two families with EDS IV, observed that only 5–10% of skin fibroblasts in tissue culture produced collagen III, instead of the normal 40% or more. The prevalence of EDS is estimated as 1/5000–1/25,000 [59, 60] and type IV represents only 4–5% of all cases. The defect in collagen III production results in marked vessel fragility leading to aneurysm, arteriovenous fistula, arterial dissection, and spontaneous arterial rupture [61].
Clinical diagnosis of vascular EDS relies on four main features [55, 56, 62]:
-
Extensive and easy bruising, frequent ecchymoses and hematomas.
-
The skin is thin and translucent, with visible veins; it is very fragile; scarring processes are abnormally prolonged, ending into enlarged scars with the aspect of cigarette paper [63].
-
Acrogeria: premature aging of the skin of extremities; this implies also a characteristic facial feature (emaciated face, sunken cheeks, nose thin and pinched, thin lips).
-
Ruptures of arteries, intestine, gravid uterus.
Skin hyperelasticity and joint hypermobility are uncommon [64], the latter being observed almost exclusively at fingers level.
Also in cases with marked phenotypic expression, diagnosis may be difficult, owing to the rarity of the disease and to the possibility of sporadic mutations, which exclude the support of a significant family anamnesis [61]. Many patients are totally unaware of their condition until a catastrophic event (vascular or visceral rupture) manifests. Median survival is 48 years [55]. Of the 31 patients collected at the Mayo Clinic from 1971 through 2001 [65], only 11 were alive at the age of 40 and 5 at the age of 60. In the same series, survival free of any complication was 84% by the age of 20 and 37% by the age of 40; survival free of vascular complications was 39% by the age of 40 and 20% by the age of 60. In the review of Pepin et al. [55], the cause of premature death of 131 patients was arterial dissection or rupture in 109 (78%) with 78 cases of rupture of the thoracic/abdominal aorta and nine cases of cerebral hemorrhage. In the series collected by Cikrit et al. [66], aortic rupture was the cause of death in 9/33 (39%). The risk of significant complications [55] was 25% by the age of 20 and more than 80% by the age of 40: of 136 patients surviving after the first complication, 52 (38%) encountered a second complication.
Arterial complications consist often on ruptures and pseudoaneurysms, but also true aneurysms are observed [65]. Cikrit et al. [66] were able to collect, in the English language literature from 1956 through 1983, 31 cases with spontaneous arterial perforation and/or aneurysmal disease, adding five personal cases: the episodes of spontaneous hemorrhage were 41, of which eight from the aorta and ten from the popliteal artery or its trifurcation; dissections and aneurysms were 28, none involving the popliteal artery. In a series (2000–2010), mainly focused on non-emergency cases, of 26 vascular EDS patients from Johns Hopkins [67], imaging studies revealed 41 aneurysms, 21 dissections, 2 stenoses, without any mention of popliteal artery involvement.
Vascular complications are also observed in the classic forms of EDS [68], both in the former type I or gravis [69] and in the type II or mitis [70, 71].
The vascular event may be the first sign of the disease [72] in as much as 80% of the cases [66]. The lack of a preoperative diagnosis of the basic disease adds to the task of the surgeon, unaware of the peculiar conditions of the vessels, and tissues in general, which he is going to handle. The more catastrophic vascular complication is represented by abrupt and life-threatening hemorrhage, deriving from a dissection or aneurysm but, very often, by an apparently normal artery. The so-called spontaneous rupture is a frequent cause of death when the brain or thoracic/abdominal cavities are involved; it represents a serious condition also when located in a limb artery, due to the very difficult management of the ruptured vessel.
Spontaneous rupture depends on the extreme fragility of the arterial wall. Sometimes a traumatic event precedes the rupture, representing an occasional and precipitating causative factor. Trauma may be relevant and not belonging to daily life activities: rupture of the splenic artery while dancing French cancan [53]; avulsion of the subclavian artery during a match of basket [73]; aortic rupture after going slide into a swimming pool and hitting the water with the abdomen [74]. However, most of these traumas are really of minor entity and would be innocuous in a normal person: rupture of the popliteal artery after an erroneous movement after turning in bed [73]; popliteal artery rupture in a 13-year-old girl after jumping up and down [75]; iliac artery rupture after lifting a small room air conditioner [66]; rupture of the thoracic aorta while cycling [76]; avulsion of the thoraco-dorsal artery after gymnastic at school [76]; rupture of the iliac artery after cycling [77]. Among limb arteries, the popliteal artery and its trifurcation look particularly at risk [66, 78]: Wright et al. [75] emphasized the role of tourniquet, in a case of popliteal artery rupture, to manage the artery in conditions of no-flow, no-pressure.
In the exhaustive review published in 2013, Bergqvist et al. [61] analyzed 231 patients, recording 93 aneurysms, 28 dissections, and 75 non-aneurysmal arterial ruptures. Of the 93 aneurysms, 16 were aortic, none popliteal. In general, reviewing the literature, it is evident that EDS IV aneurysms may affect any large- or medium-size artery: aorta [74, 79,80,81,82]; subclavian [63]; intracranial arteries [83, 84]; carotid and vertebral [85, 86]; iliac [87]; femoral [85, 88]; infrapopliteal arteries [89, 90]. In 1996, Freeman et al. [91] reviewed 17 patients with several aneurysms (12 aortic, 2 subclavian, 4 carotid, 1 vertebral, 1 hepatic, 1 of the superior mesenteric artery). In 2000, Parfitt et al. [92] reported a series of visceral aneurysms: three splenic, three hepatic, three renal (bilateral in two patients), two coeliac, two of the superior mesenteric artery.
Arteriovenous fistulae are frequently reported, assuming particular relevance when involving the internal carotid and the cavernous sinus [83].
Aneurysms of the popliteal artery are very rare. Stella et al. [81] report the angiographic finding of bilateral dilation of the popliteal artery in a case of multiple aneurysms. Zilocchi et al. [93], reviewing the imaging studies of 28 patients (Mayo Clinic, 1971–2006), observed anomalies of the femoro-popliteal tract in three patients and ascertained the presence of a popliteal aneurysm, together with a femoral aneurysm, in a 50-year-old male patient.
Several patients affected with vascular EDS experience different and multiple arterial complications in the course of their life. Bellenot et al. [94] treated, during a 9-month period, the successive ruptures of left iliac, right iliac and hepatic arteries in a 25-year-old male patient. Grundtner et al. [82] performed more than ten open and endovascular procedures to extend the life of a patient from 11 to 27 years when he succumbed to the rupture of a previously ligated splenic artery aneurysm.
Treatment of arterial lesions of EDS IV is difficult and often unrewarding. Diagnostic angiography is a dangerous procedure owing to the heavy complications consequent to arterial puncture and as well, and more important, to the damage from inside procured by guide-wires, catheters, and injection pressure. After the initial warning [95], a complication rate of 16–67% and a mortality of 6–19% were put into evidence [66, 91]. Angio-CT and angio-RM are currently the recommended diagnostic methods. The surgeon, often without any knowledge about the condition of the patient, finds very fragile vessels: handling and suturing are demanding and frequently disappointing. Vascular clamps, even if padded, can result in arterial transection [76, 96,97,98]. Blood vessel walls have a wet-tissue or blotting-paper consistency and fail to hold sutures [63, 99, 100]. The key to be successful in such operations [97] relies on the preoperative diagnosis of EDS and the use of a surgical technique ad hoc: by general consensus, try to avoid clamps and to achieve hemostasis by balloon occlusion; to use interrupted sutures reinforced with Teflon pledgets; to obtain final hemostasis with glues and prolonged compression. Whenever possible, ligation should be preferred to reconstructive procedures [63, 66, 75, 101], performing avoiding trauma too close to vessels by using umbilical tape-like material or interposing a strip of synthetic graft between the vessel and the ligature.
Successful reconstructive procedures are seldom reported [66, 72, 77, 80,81,82] and a diffuse opinion is that surgery should be performed only in the emergency setting and only in real life- (or limb-) threatening situations [92]; hemodynamically stable patients with arterial rupture should be managed conservatively, through immobility in bed, compression, and blood transfusions [101]. Bergqvist et al. [61] seem to attribute to this conservative attitude the reduction in mortality from 50% to 39% between two series of patients, 112 up to 1996 and 119 after 1996. Opinions, however, are not uniform. Two very important reports were aired, one from Mayo Clinic [65] and the other from Johns Hopkins [102]. The former includes only vascular EDS patients and agrees with the abovementioned tendency: 15 patients were submitted to open or endovascular procedures and of these 70% were performed in emergency. The latter relies on 40 patients submitted, almost exclusively in election, to open or endovascular treatment for vascular complications of EDS (classical type 15, hypermobile 16, vascular 9). Operations on vascular EDS patients were performed for aortic involvement and a mortality of 22% (2/9) was observed. The authors conclude that elective procedures should be privileged, to avoid the rather disappointing results of emergency procedures.
Endovascular procedures in EDS IV have been performed on several occasions to achieve occlusion of a bleeding artery [103] or of a visceral aneurysm [104, 105]. Consensus exists on the effectiveness of embolization procedures when feasible [65, 102] and of balloon occlusion of carotid-cavernous fistulae [106]. All these procedures are obviously exposed to dangers analogue (and enhanced) to those of catheter angiography, sometimes with catastrophic evolution [107]. Stent-grafting of an aortic aneurysm (patient with classic or type I EDS) has been successfully performed [101] and applied also on visceral [108] and peripheral arteries [82, 87, 109]. However, stent-grafting looks to be not strongly recommended, due to the risk of perforation and erosion at the fixation zone and the high incidence of reinterventions [110, 111]; apart the risks inherent to endovascular manipulations, large-bore tools, large angio-accesses. In the 1996–2010 review by Bergqvist et al. [61], mortality was 30% (13/44) after open procedures and 24% (8/33) after endovascular treatment.
Finally, it must be mentioned that Celiprolol (ß-1-adrenergic antagonist and ß-2-adrenergic agonist) has been used in a randomized trial [112], demonstrating, during a mean follow-up of 47 months, a significant ability to reduce the occurrence of arterial dissection/rupture in vascular EDS patients.
3 Loeys–Dietz Syndrome
Loeys–Dietz syndrome (LDS) is a rare autosomal dominant disorder causing a diffuse disease of the connective tissue and predisposing individuals to aortic and arterial aneurysms [113].
Loeys et al. [14] described the syndrome in 2005, identifying its genetic origin in a mutation of the TGF-ß receptor; after one year [114] they published an exhaustive clinical report, relying on 52 families and 90 patients. The disease was characterized by a triad of signs: arterial tortuosity and aneurysms, hypertelorism, bifid uvula or cleft palate; about 25% of the families presented the phenotype of vascular Ehlers–Danlos syndrome, which was ruled out by studies of the type III collagen. In this early series, median survival was 37 years; 27 patients died at the mean age of 26, and the most common cause of death was thoracic or abdominal aorta dissection (89%), followed by intracerebral bleeding (7%).
Ritelli et al. [115], reviewing the current knowledge about this syndrome, recognize four types, all deriving from mutations in genes of the TGF-ß signaling pathway. LDS1 and LDS2 patients are prone to major vascular events and have a short life expectancy [116]; they frequently present cutaneous signs similar to those observed in the Ehlers–Danlos syndrome. LDS3 patients too present important vascular manifestations, together with skeletal deformities and, frequently, osteo-arthritis at a young age [117]. In LDS4 patients, the vascular phenotype looks less aggressive and less life-threatening; aortic aneurysms and dissections are less frequent and manifest later [115].
Surgical and/or endovascular treatment of aneurysms in LDS patients, in the light of the still scarce experience so far gained, appears gratifying [118,119,120] especially when the results are compared with those obtained in Ehlers–Danlos syndrome. A careful surveillance of the patient and an aggressive attitude toward new successive vascular events can assure prolonged and satisfactory life as demonstrated by Beckman et al. [121]: a man, initially treated at the age of 38 for an aortic dissection Stanford type A, was still alive and actively working 25 years later, after repeated treatments for involvement of thoracic and abdominal aorta and of iliac, femoral, carotid, and subclavian arteries. Reporting in 2015 the experience at Duke University Hospital, in Durham, Williams et al. [122] observed that 10 out of 11 patients surgically treated were alive after a mean follow-up of 60 months (8.4–172); the patients were aged 20–58 years when first treated by the Duke team, and 7 of them had already been submitted to surgery elsewhere.
Involvement of peripheral arteries is not frequent [123], but the rarity of reports [119, 124] could derive from the prevailing clinical role of aortic dissections and aneurysms [125]. A review of the literature allowed to find three cases of popliteal aneurysms (Table 26.2), all treated with apparent good result. In one case [125] vein grafting was complicated by aneurysmal dilation of the graft, which was substituted with a PTFE prosthesis; microscopically, the graft showed “diffuse fragmentation and loss of the elastic fibers with an increase of proteoglycan material that formed pools between the remaining elastic lamellae.” This picture was similar to that observed in arterial specimens obtained in LDS patients; the dilation would recognize, according to this finding, the same underlying pathology of arterial disease. Similarly, aneurysms in vein grafts used in the treatment of atherosclerotic disease are attributed to atherosclerotic involvement [126].
References
Marfan A. Un cas de déformation congénitale des quatre membres, plus prononcée aux etrémités, charactérisée par l’allongement des os avec un certain degré d’amincissement. Bull Soc Méd Hôp. Paris. 1896;18:220.
Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150–7.
Sakai IK, Keene DR, Engvall F. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986;103:2499–509.
Pereira I, D’Alessio M, Ramirez F, Lynch IR, Sykes R, Pangillinan T, Ronadin I. Genomic organization for the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet. 1993;2:961–8.
Murdoch H, Walker RA, Halpern RI, Kuzma IW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med. 1972;286:804–8.
McKusick VA. Heritable disorders of connective tissue. The Marfan syndrome, vol. 1960. St. Louis, MO: C.V. Mosby Co.; 1960. p. 348–52.
De Paepe A, Devereux RR, Dietz HC, Hennekam RCM, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62:417–26.
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–85.
Peters DJM, Sandkuijl LA. Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol. 1992;97:128–39.
Hataboer N, Buchalter M, Davies SJ, Lazarou LP, Ravine D. Co-occurrence of autosomal dominant polycystic kidney disease and Marfan syndrome in a kindred. Am J Kidney Dis. 2000;35:753–60.
Palestini M, Douitsis E, Teofili MT, Vecchi L, Toscano C, Cavallaro A. Abdominal aortic aneurysm in patients submitted to chronic hemodyalisis for autosomal dominant polycystic kidney disease: personal experience. Int J Angiol. 1994;3:90–2.
Keane M, Pyeritz R. Medical management of Marfan syndrome. Circulation. 2008;117:2802–13.
Yetman AT, Roosevelt GE, Veit N, Everitt MD. Distal aortic and peripheral arterial aneurysms in patients with Marfan syndrome. J Am Coll Cardiol. 2011;58:2544–5.
Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37:275–81.
Gaertner S, Alembik Y, Cordeanu E-M, Dollfus H, Lejay A, Chakfe N, Stephan D. Should we systematically screen for peripheral arterial aneurysms in all patients with Marfan syndrome? Int J Cardiol. 2014;172:e94–5.
Imawaki S, Maaeta H, Shiraishi Y, Arioka I, Karasawa Y, Shinohara T, Tanaka T. Decrease in aortic distensibility after an extended aortic reconstruction for Marfan’s acute aortic dissection DeBakey type I: a report of two cases. Surg Today. 1993;23:1010–3.
Stewart GW, Elizondo ER, Haper K, Biundo JJ Jr. Paraplegia in a patient with Marfan’s syndrome as a result of thoracoabdominal aortic aneurysm repair. Arch Phys Med Rehabil. 1994;75:921–3.
Takayama T, Miyata T, Nagawa H. True abdominal aortic aneurysm in Marfan syndrome. J Vasc Surg. 2009;49:1162–5.
Ugwu BT, Ardill W, Yiltok SJ, Momoh JT, Lenkop DW, Uba FA. Marfan’s syndrome presenting with abdominal aortic aneurysm. A case for vigilance. West Afr J Med. 2003;22:95–7.
Lafferty K, McLean L, Salisbury J, Cotton LT. Ruptured abdominal aortic aneurysm in Marfan’s syndrome. Postgrad Med J. 1987;63:685–7.
Roberts WC, Honig HS. The spectrum of cardiovascular disease in the Marfan syndrome: a clinicomorphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients. Am Heart J. 1982;104:115–35.
Wolfgarten B, Kruger I, Gawenda M. Rare manifestation of abdominal aortic aneurysm and popliteal aneurysm in a patient with Marfan’s syndrome. A case report. Vasc Surg. 2001;35:81–4.
Tijani Y, Mameli A, Chtata H, Taberkant M, Lekehal B, Sefiani Y, Elmesnaoui A, Ammar F, Bensaid Y, Feito B, Bellenot F, Fallouh A, Cheysson E. Association exceptionnelle d’un anévrysme poplité bilateral et d’un anévrysme de l’aorte abdominale au cours d’un syndrome de Marfan. J Mal Vasc. 2014;39:278–81.
Gonzalez JMD, Garcia BA, Lebrun JM, Docampo MM. Combined surgery for the treatment of bilateral subclavian artery aneurysm in Marfan syndrome. J Vasc Surg. 2007;45:180–2.
Bowman JN, Ellozy SH, Plestis H, Marin ML, Faries PL. Hybrid repair of bilateral subclavian artery aneurysm in a patient with Marfan syndrome. Ann Vasc Surg. 2010;24:114.e1–5.
Tassiopoulos AK, Nadalin BA, Labropoulos N, Egofske P, Keen RR. Endovascular repair of a symptomatic subclavian artery aneurysm in a patient with Marfan syndrome: a case report. Vasc Endovasc Surg. 2006;40:409–13.
Saito Y, Taniguchi S, Watanabe K, Fukui K, Fukuda Y. Bilateral axillary artery aneurysm in siblings with Marfan syndrome. Ann Vasc Surg. 2014;28:740e13–6.
Nguyen DQ, Murison M. Ulnar artery aneurysm in a patient with Marfan’s syndrome. J Plast Reconstr Aesthet Surg. 2006;59:1131–2.
Hardin CA. Successful resection of carotid and abdominal aneurysm in two related patients with Marfan’s syndrome. N Engl J Med. 1962;267:141–2.
Latter DA, Ricci MA, Forbes RD, Graham AM. Internal carotid artery aneurysm and Marfan’s syndrome. Can J Surg. 1989;32:463–6.
Stajzel R, Hefft S, Girardet C. Marfan’s syndrome and multiple extracranial aneurysms. Cerebrovasc Dis. 2001;11:346–9.
Bouziane Z, Bensaid B, El Idrissi R, Mesnaoui AE, Bensaid Y, Ratbi I. Marfan syndrome and internal carotid artery aneurysm. Vasa. 2013;42:457–60.
Croisile B, Deruty R, Pialat J, Chazot G, Jourdan C. Anévrysme de la carotid supra-clinoidienne et mega-dolicho-artères cervicales dans un syndrome de Marfan. Neurochirurgie. 1988;34:342–7.
Ohyama T, Ohara S, Momma F. Aneurysm of the cervical internal carotid artery associated with Marfan’s syndrome: case report. Neurol Med Chir. 1992;32:965–8.
Conway JE, Hutchins GM, Tamargo RJ. Marfan syndrome is not associated with intracranial aneurysms. Stroke. 1999;30:1632–6.
Crivello MS, Porter DH, Kim D, Critchlow JF, Scoutt L. Isolated external iliac aneurysm secondary to cystic medial necrosis. Cardiovasc Intervent Radiol. 1986;9:139–41.
Flanagan PV, Geoghegan Y, Egan TJ. Iliac artery aneurysm in Marfan’s syndrome. Eur J Vasc Surg. 1990;4:323–4.
Savolainen H, Savola J, Savolainen A. Aneurysm of the iliac artery in Marfan’s syndrome. Ann Chir Gynaecol. 1993;82:203–5.
Patra S, Singh AP, Srivinas BC. Marfan syndrome with spontaneous rupture of aneurysm of common iliac artery. Indian Pediatr. 2013;50:507–8.
Aschwanden M, Wegmann W. Aneurysma dissecans der Arteria iliaca communis bei Marfan-Syndrome. Ruptur nach sportlicher Betatigung. Schweiz Med Wschr. 1990;120:836–9.
Mounier-Vehier C, Millaire A, Vrtovsnik F, Marache P, Ducloux G. Dissecting aneurysm of the left iliac artery disclosing Marfan’s disease. Ann Cardiol Angeiol. 1991;40:537–40.
Bozzani A, Arici V, Odero A. Modified stent-graft sandwich technique for treatment of isolated common iliac artery aneurysm in a patient with Marfan syndrome. Ann Vasc Surg. 2012;26:884–5.
Yoshida RA, Yoshida WB, Kolvenbach R, Vieira PR. Modified stent graft sandwich technique for treatment of isolated common iliac artery aneurysm in patient with Marfan syndrome. Ann Vasc Surg. 2012;26:419e7–9.
Hatrick AG, Malcolm PN, Burnand KG, Irvine AT. A superficial femoral artery aneurysm in a patient with Marfan’s syndrome. Eur J Vasc Endovasc Surg. 1998;15:459–60.
Al HW, Goldsmith DJA. Bilateral popliteal aneurysms complicating adult polycystic kidney disease in a patient with marfanoid habitus. Postgrad Med J. 2003;79:474–5.
Ehlers E. Cutis laxa. Neigung zu Haemorrhagien in der Haut, Lockerung mehrerer Artikulationen. Dermatol Ztschr. 1901;8:173–4.
Danlos H-A. Un cas de cutis laxa avec tumeur par contusion chronique des coudes et des genoux (xanthome juvenile pseudodiabetique de Mm. Hallopeault et Macé de Lépinay). Bull Soc Franç Dermatol Syph. 1908;19:70–2.
Tschernogobow NA. Uber einem Fall von Cutis laxa. Monat Prakt Dermatol. 1892;15:76.
Van Meekren J. Observationes medico-chirurgicae de belgico in latinum translatae. H. & Wid. T. Boom, Amstelodami; 1682.
Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet. 1998;77:31–7.
Sack G. Status dysvascularis, ein Fall von besonderer Zerreiblichkeit der Blutgefasse. Dtsch Arch Klin Med. 1936;178:663–9.
Barabas AP. Heterogeneity of the Ehlers-Danlos syndrome: description of three clinical types and a hypothesis to explain the basic defect(s). Br Med J. 1967;2:612–3.
Barabas AP. Vascular complications in the Ehlers-Danlos syndrome, with special reference to the arterial type or Sack’s syndrome. J Cardiovasc Surg. 1972;13:160–7.
Beighton P. The Ehlers-Danlos syndrome. London: W. Heinamnn; 1970.
Pepin M, Schwarze U, Superti-Fuga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673–80.
Germain DP, Herrera-Guzman Y. Vascular Ehlers-Danlos syndrome. Ann Genet. 2004;47:1–9.
Pope M, Martin GR, VA MK. Inheritance of Ehlers-Danlos syndrome. J Med Genet. 1977;14:200–4.
Cikrit DF, Glover JR, Daising MC, Silver D. The Ehlers-Danlos syndrome revisited. Vasc Endovasc Surg. 2002;36:213–7.
Byers PH. Ehlers-Danlos syndrome. In: Rimoin DL, Connor JM, Pyeritz RE, editors. Emery and Rimoin’s principles and practice of medical genetics, vol. 1. New York, NY: Churchill-Livingstone; 1997. p. 1067–81.
Pyeritz RE. Ehlers-Danlos syndrome. N Engl J Med. 2000;342:730–2.
Bergqvist D, Björck M, Wanhainen A. Treatment of vascular Ehlers-Danlos syndrome: a systematic review. Ann Surg. 2013;258:257–61.
Germain DP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007;2:32.
Hunter GC, Malone JM, Moore WS, Misiorowski RL, Chvapil M. Vascular manifestations in patients with Ehlers-Danlos syndrome. Arch Surg. 1982;117:465–8.
Sheiner MN, Miller N, Lachance C. Arterial complications of Ehlers-Danlos syndrome. J Cardiovasc Surg. 1985;26:291–6.
Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KG, Noel AA, Kalra M, Sullivan T, Gloviczki P. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2006;42:98–106.
Cikrit DF, Miles JH, Silver D. Spontaneous arterial perforation: the Ehlers-Danlos specter. J Vasc Surg. 1987;5:248–55.
Chu LC, Johnson PT, Dietz HC, Brooke BS, Arnaoutakis GJ, Black JHIII, Fishman BS. Vascular complications of Ehlers-Danlos syndrome. Am J Roentgenol. 2012;198:482–7.
Borek G, Beighton P, Wilhelm C, Kohlhase J, Kubisch C. Arterial rupture in classic Ehlers-Danlos syndrome with COL5A1 mutation. Am J Med Genet. 2010;152A:2094–8.
Beighton P, Horan FT. Surgical aspects of the Ehlers-Danlos syndrome. A survey of 100 cases. Br J Surg. 1969;56:255–9.
Bowers WH, Spencer JB, McDevitt NB. Brachial artery rupture in Ehlers-Danlos syndrome: an unusual cause of high median-nerve palsy. J Bone Joint Surg. 1976;58:1025–6.
Mirza FH, Smith PL, Lim WN. Multiple aneurysms in a patient with Ehlers-Danlos syndrome: angiography without sequelae. Am J Roentgenol. 1979;132:993–5.
Imamura A, Nakamoto H, Inoue T, Yamada H, Okuno M, Takai S, Komada H, Kwon AH, Kamyama Y. Ruptured dissecting aneurysm in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a case. Surg Today. 2001;31:85–9.
McFarland W, Fuller DE. Mortality in Ehlers-Danlos syndrome due to spontaneous rupture of large arteries. N Engl J Med. 1964;271:1309–10.
Karkos CD, Prasad V, Mukhopadhyay U, Thomson GJL, Hearn AR. Rupture of the abdominal aorta in patients with Ehlers-Danlos syndrome. Ann Vasc Surg. 2000;14:274–7.
Wright CB, Lamberth WC, Ponsetti IV, Hanson J. Successul management of popliteal artery disruption in Ehlers-Danlos syndrome. Surgery. 1979;85:708–12.
Lauwers G, Nevelsteen A, Daenen G, Lacroix H, Suy R, Frijns J-P. Ehlers-Danlos syndrome type IV: a heterogeneous disease. Ann Vasc Surg. 1997;11:178–82.
Bronzino P, Abbo L, Bagnasco F, Barisone P, Dezzani AM, Genovese AM, Iannucci P, Ippoliti M, Sacchi M, Aimo I. Rottura spontanea di arteria iliaca comune: descrizione di un caso e revisione della letteratura. G Chir. 2006;27:324–7.
Beylot C, Bioulac P, Doutre MS. Les manifestations artérielles du syndrome d’Ehlers-Danlos. Ann Med Int. 1983;134:451–7.
Lynch HT, Larsen AL, Wilson R, Magnuson CL. Ehlers-Danlos syndrome and congenital arteriovenous fistulae. A clinicopathologic study of a family. JAMA. 1965;194:1011–4.
Burnett FH, Bledsoe JH, Char F, Williams D. Abdominal aortic aneurysm in a 17-year-old patient with Ehlers-Danlos syndrome: case report and review of the literature. Surgery. 1973;74:617–20.
Stella A, Gessaroli M, Cifiello BI, Mirelli M, Loperfido V, Riva R, Guizzardi S. Sack-Barabas syndrome (Ehlers-Danlos IV type) (clinic and histopathologic ultrastructural correlations). Vasc Endovasc Surg. 1986;20:67–73.
Grundtner P, Assadian A, Senekowitsch C, Plakovsky H, Mendel H, Hagmuller GW. History of a patient with Sack-Barabas syndrome (Ehlers-Danlos type IV) – 16 years of recurrent life-extending open and endovascular surgery. Eur J Vasc Endovasc Surg Extra. 2005;9:107–10.
North KN, Whiteman DA, Pepin MG, Byers PH. Cerebrovasculat complications in Ehlers-Danlos syndrome type IV. Ann Neurol. 1995;38:960–4.
Kato T, Hattori H, Yorifuji TJ, Tashiro Y, Nakahata T. Intracranial aneurysms in Ehlers-Danlos syndrome type IV in early childhood. Pediatr Neurol. 2001;25:336–9.
Bannerman RM, Graf CJ, Upson JF. Ehlers-Danlos syndrome. Br Med J. 1967;3:558–9.
Brodribb AJM. Vertebral aneurysm in a case of Ehlers-Danlos syndrome. Br J Surg. 1970;57:148–51.
Tonnessen BH, Sternbergh WC III, Mannava K, Money SR. Endovascular repair of an iliac artery aneurysm in a patient with Ehlers-Danlos syndrome type IV. J Vasc Surg. 2007;45:177–9.
Witz M, Lehmann JM. Aneurysmal arterial disease in a patient with Ehlers-Danlos syndrome. Case report and literature review. J Cardiovasc Surg. 1997;38:161–3.
Hagspiel KD, Bonatti H, Sabri S, Arslan B, Hartun NL. Metachronous bilateral posterior tibial artery aneurysms in Ehlers-Danlos syndrome type IV. Cardiovasc Intervent Radiol. 2010;34:413–8.
Domenick N, Cho JS, Abu HG, Makaroun MS, Chaer RA. Endovascular repair of multiple infragenicular aneurysms in a patient with vascular type Ehlers-Danlos syndrome. J Vasc Surg. 2011;54:848–50.
Freeman RK, Swegle J, Sise MJ. The surgical complications of Ehlers-Danlos syndrome. Am Surg. 1996;62:869–73.
Parfitt J, Chalmers RTA, Wolfe JHN. Visceral aneurysms in Ehlers-Danlos syndrome: case report and review of the literature. J Vasc Surg. 2000;31:1248–51.
Zilocchi M, Macedo TA, Oderich GS, Vrtiska TJ, Biondetti PR, Stanson AW. Vascular Ehlers-Danlos syndrome: imaging findings. Am J Roentgenol. 2007;180:712–9.
Bellenot F, Boisgard S, Kantelip B, Maillard P, Tissandier P, Ribal JP, Glanddier G. Type IV Ehlers-Danlos syndrome with isolated arterial involvement. Ann Vasc Surg. 1990;4:15–9.
Slingenberg EJ. Complications during intravascular diagnostic manipulations in the Ehlers-Danlos syndrome. Neth J Surg. 1980;32:56–8.
Van Selms WG, Yo IT, Kuiken H. Spontaneous rupture of the external iliac artery in a patient with Ehlers-Danlos syndrome type IV. Eur J Vasc Surg. 1990;4:419–21.
Mattar SG, Kumar AG, Lumsden AB. Vascular complications in Ehlers-Danlos syndrome. Am Surg. 1994;60:827–31.
Bergqvist D. Ehlers-Danlos type IV syndrome: a review from a vascular surgical point of view. Eur J Surg. 1996;162:163–70.
Krog M, Almgren B, Eriksson I, Nordstrom S. Vascular complications in the Ehlers-Danlos syndrome. Acta Chir Scand. 1983;149:279–82.
Serry C, Agomuoh OS, Goldin MD. Review of Ehlers-Danlos syndrome: successful repair of rupture and dissection of abdominal aorta. J Cardiovasc Surg. 1988;29:530–4.
Bade MA, Queral LA, Mukherjee NT, Kong LS. Endovascular abdominal aortic aneurysm repair in a patient with Ehlers-Danlos syndrome. J Vasc Surg. 2007;46:360–2.
Brooke BS, Arnaoutakis G, McDonnell MB, Black JHIII. Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010;51:131–8.
Sugawara Y, Ban K, Imai K, Okada K, Watari M, Orihashi K, Sueda T, Naitoh A. Successful coil embolization for spontaneous arterial rupture in association with Ehlers-Danlos syndrome type IV. Report of a case. Surg Today. 2004;34:94–6.
Calvo P, Lanciego C, Krasniqi G, Cereceda C, Morlan MA, Vega A, Ruizf G-GC. Successful endovascular treatment of a splenic artery aneurysm in a patient with Ehlers-Danlos syndrome. J Vasc Interv Radiol. 2009;20:274–5.
Nosher JL, Trooskin SZ. Occlusion of a hepatic arterial aneurysm with Gianturco coils in a patient with the Ehlers-Danlos syndrome. Am J Surg. 1986;152:326–8.
Debrun GM, Aletich VA, Miller NR, DeKeiser BJW. Three cases of spontaneous direct carotid cavernous fistulas associated with Ehlers-Danlos syndrome type IV. Surg Neurol. 1996;46:247–52.
Horowitz MB, Purdy PD, Valentine RJ, Merrill K. Remote vascular catastrophes after neurovascular interventional therapy for type IV Ehlers-Danlos syndrome. Am J Neuroradiol. 2000;21:974–6.
Casana R, Nano G, Dalainas I, Tealdi DG. Endovascular treatment of hepatic artery aneurysm in a patient with Ehlers-Danlos syndrome: case report. Int Angiol. 2004;23:291–5.
Iida Y, Obitsu Y, Komai H, Shigematsu H. Successful coil embolization for rupture of the subclavian artery associated with Ehlers-Danlos syndrome type IV. J Vasc Surg. 2009;50:1191–5.
Geisbusch P, Kotelis D, von Tengg-Kobliqk H, Hyhlik-Durr A, Allenberg JA, Bockler D. Thoracic aortic endografting in patients with connective tissue disease. J Endovasc Ther. 2008;15:144–9.
Svensson LG, Kouchoukos NT, Miller DC, Bavaria JE, Coselli JS, Curi MA, Society of Thoracic Surgeons Endovascular Surgery Task Force. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg. 2008;85(Suppl):S1–S41.
Ong KT, Perdu J, De Backer J, Bozec E, Collignon P, Emmerich J, Fauret AL, Fiessinger JN, Fermain DP, Georgesco G, Hulot JS, De Paepe A, Plauchu H, Jeunemaitre X, Laurent S, Boutouyrie P. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomized, open, blinded-endpoints trial. Lancet. 2010;376:1476–84.
McCarrick G, Black JHIII, Bowdin S, El-Hamamsi I, Frischmeyer-Guerrerio PA, Guerrerio AL, Sponseller PD, Loeys B, Dietz HCIII. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med. 2014;16:576–87.
Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens P, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndrome caused by mutations in the TGF-beta receptor. N Engl J Med. 2006;355:788–98.
Ritelli M, Chiarelli N, Dordoni C, Quinzani S, Venturini M, Maroldi R, Calzavara-Pinton P, Colombi M. Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation. BMC Med Genet. 2014;15:91.
Van Hemelrijk C, Renard M, Loeys B. The Loeys-Dietz syndrome: an update for the clinicians. Curr Opin Cardiol. 2010;25:546–51.
Van de Lar IM, Van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-Zeinstra SM, van Meer BL, Pals G, Oldenburg RA, Bekkers JA, Moelker A, de Graaf BM, Matyas G, Frohn-Mulder IM, Timmermans J, Hilhorst-Hofstee Y, Cobben JM, Bruggenwirth HT, van Laer L, Loeys B, De Backer J, Coucke PJ, Dietz HC, Willems PJ, Oostra BA, De Paepe A, Roos-Hesselink JW, Bertoli-Avella AM, Wessels MW. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthriris syndrome. J Med Genet. 2012;49:47–57.
Neri E, Tommasino G, Tucci E, Benvenuti A, Ricci C. A complex thoracoabdominal aneurysm in a Loeys-Dietz patient: an open, hybrid, anatomic repair. Ann Thorac Surg. 2010;90:e88–90.
Casey K, Zayed M, Greenberg JI, Dalman RL, Lee JT. Endovascular repair of bilateral iliac artery aneurysms in a patient with Loeys-Dietz syndrome. Ann Vasc Surg. 2012;26:107e5–107e10.
Ozker E, Vuran C, Saritas B, Türköz R. Valve-sparing replacement of the ascending aorta and aortic arch in a child with Loeys-Dietz syndrome. Eur J Cardiovasc Thorac Surg. 2012;41:1184–5.
Beckman E, Stiefel P, Shresrta M, Haverich A, Martens A. Surgical experience in a patient with Loeys-Dietz syndrome type I. Ann Thorac Surg. 2014;97:e125–7.
Williams JA, Hanna JM, Shah AA, Andersen ND, McDonald MT, Jiang YH, Wechsler SB, Zomorodi A, McCann RL, Hughes GC. Adult surgical experience with Loeys-Dietz syndrome. Ann Thorac Surg. 2015;99:1275–81.
Black JH III. Aneurysms caused by connective tissue abnormalities. In: Cronenwett JR, Johnston KW, editors. Rutherford’s vascular surgery. 8th ed. Philadelphia, PA: Elsevier; 2014. p. 2248–67.
Martens T, Van Herzeele I, De Ryck F, Renard M, De Paepe A, François K, Vermasson F, De Backer J. Multiple aneurysms in a patient with aneurysms-osteoarthritis syndrome. Ann Thorac Surg. 2013;95:332–5.
Kuma S, Ishida M, Okazaki J, Arai Y, Hanyu M, Inoue K. Giant vein graft aneurysm complicated by Loeys-Dietz syndrome. J Vasc Surg Cases. 2015;1:123–6.
Loftus JM, Mc Carthy MJ, Lloyd A, Naylor AR, Bell PR, Thompson MM. Prevalence of true vein graft aneurysms: implications for aneurysm pathogenesis. J Vasc Surg. 1999;29:403–8.
Johnson PT, Chen JK, Loeys BL, Dietz HC, Fishman EK. Loeys-Dietz syndrome: MDCT angiography findings. Am J Roentgenol. 2007;189:W29–35.
Stephenson MA, Vlachakis I, Valenti D. Bilateral popliteal artery aneurysms in a young man with Loeys-Dietz syndrome. J Vasc Surg. 2012;56:486–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cavallaro, A. (2021). Disorders of the Connective Tissue. In: Cavallaro, A. (eds) Aneurysms of the Popliteal Artery. Springer, Cham. https://doi.org/10.1007/978-3-030-49687-6_26
Download citation
DOI: https://doi.org/10.1007/978-3-030-49687-6_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-49686-9
Online ISBN: 978-3-030-49687-6
eBook Packages: MedicineMedicine (R0)